https://www.fredhutch.org/en/news/releases/rss2015-05-20T17:02:01.631ZNews Releases RSS FeedAdobe Experience ManagerFred Hutch researchers present at ASCO 2015 Annual meetingA number of investigators from Fred Hutchinson Cancer Research Center will share new research findings at the annual meeting of the American Society of Clinical Oncology, or ASCO, which is being held May 29–June 2 in Chicago. The theme of this year’s gathering is “Illumination & Innovation: Transforming Data into Learning.”https://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-researchers-present-at-asco2015-05-29T16:19:53.000Z2015-05-29T16:19:53.000ZFred Hutch and Uganda Cancer Institute open UCI-Fred Hutch Cancer Centre in Kampalahttps://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-uganda-cancer-institute-open-cancer-centre-in-kampala2015-05-21T21:11:00.000Z2015-05-21T21:11:00.000ZFred Hutch Researchers discover tumor molecule that causes spread of pancreatic cancerA single molecule switches on metastasis, or spread, in pancreas cancers, reports new research led by scientists at Fred Hutchinson Cancer Research Center. The researchers predict that testing for this molecule, called RUNX3, could very soon help oncologists choose the most appropriate treatments based on the metastatic potential of each patient’s disease.https://www.fredhutch.org/en/news/releases/2015/05/researchers-discover-tumor-molecule-spread-pancreatic-cancer2015-05-21T15:53:25.000Z2015-05-21T15:53:25.000ZFred Hutch geneticist and biologist Sue Biggins selected as a Howard Hughes Medical Institute investigator Sue Biggins, Ph.D., a geneticist and biologist at Fred Hutchinson Cancer Research Center who studies the machinery that dividing cells use to ensure their daughter cells receive the correct allotment of chromosomes, has been selected to become a Howard Hughes Medical Institute investigator. She is among 26 of the nation’s top biomedical scientists to receive the honor this year out of a pool of nearly 900 applicants.https://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-researcher-sue-biggins-selected-hhmi-investigator2015-05-19T17:58:13.000Z2015-05-19T17:58:13.000ZSpace Needle, in partnership with Fred Hutchinson Cancer Research Center, opens registration for first public stair climb in the landmark’s historyhttps://www.fredhutch.org/en/news/releases/2015/05/space-needle-fred-hutch-first-public-stair-climb2015-05-07T19:14:56.000Z2015-05-07T19:14:56.000ZNew technique allows researchers to see gene activity in single cells in a living animal for the first timeFor the first time, researchers can see and reliably measure how genes turn on and off in individual cells in a living animal — and they can track that gene activity through the animal’s entire life. This new technique, described in a paper published Wednesday in the journal PLOS ONE, will allow researchers to explore heretofore unanswered questions about the role of random variation in cancer and aging, said Fred Hutchinson Cancer Research Center molecular biologist Roger Brent, Ph.D., who led the study.
https://www.fredhutch.org/en/news/releases/2015/05/technique-allows-researchers-see-gene-activity2015-05-06T22:16:41.000Z2015-05-06T22:16:41.000ZNobel Laureate and Fred Hutch researcher Linda Buck elected to Royal SocietyNobel Laureate Linda Buck, Ph.D., researcher at Fred Hutchinson Cancer Research Center, has been elected to the Royal Society as a foreign member.https://www.fredhutch.org/en/news/releases/2015/05/linda-buck-elected-to-royal-society2015-05-01T15:41:01.000Z2015-05-01T15:41:01.000ZGenetic counseling linked to increased use of preventive ovary removal in women at high risk for ovarian cancerA randomized clinical trial conducted by M. Robyn Andersen, Ph.D., M.P.H., and colleagues at Fred Hutch has found, for the first time, that proactively offering genetic counseling to women at high risk of ovarian cancer can increase the use of prophylactic oophorectomy, or preventive ovary removal.https://www.fredhutch.org/en/news/releases/2015/04/genetic-counseling-increases-preventive-ovary-removal2015-04-24T17:29:29.000Z2015-04-24T17:29:29.000ZStudy finds that microinjection platform enables assessment of multiple cancer drugs directly in tumors, predicts systemic responseA newly developed technology for simultaneously comparing response to multiple cancer drugs or combinations while a tumor is still in a patient’s body has been shown to accurately predict systemic response to the drugs, according to researchers at Fred Hutchinson Cancer Research Center and Presage Biosciences. The patented technology, called CIVO™, consists of an arrayed microinjection drug delivery device and quantitative analysis methodology.https://www.fredhutch.org/en/news/releases/2015/04/microinjection-platform-enables-assessment-multiple-cancer-drugs2015-04-22T07:00:00.000Z2015-04-22T07:00:00.000ZObesity significantly increases prostate cancer risk in African-American men, study findshttps://www.fredhutch.org/en/news/releases/2015/04/obesity-ups-prostate-cancer-risk-in-black-men2015-04-16T16:27:08.000Z2015-04-16T16:27:08.000ZSelenide protects heart muscle in the wake of cardiac arrestDamage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study by Mark Roth, Ph.D., and colleagues at Fred Hutchinson Cancer Research Center.https://www.fredhutch.org/en/news/releases/2015/04/selenide-protects-heart-in-cardiac-arrest2015-04-09T18:08:33.000Z2015-04-09T18:08:33.000ZFred Hutch’s Obliteride announces a fun new ride benefiting women’s cancer researchFred Hutch’s Obliteride launches a new ride for people who are passionate about ending cancer, especially those afflicting women. The 10-mile pedal will take people on a controlled course around Lake Union Aug. 9, 2015, starting at Fred Hutch and ending at Gas Works Park for a celebration party. https://www.fredhutch.org/en/news/releases/2015/04/obliteride-announces-new-ride-benefiting-cancer-research2015-04-09T17:56:03.000Z2015-04-09T17:56:03.000ZThe link between aspirin, NSAIDs and colon cancer prevention may hinge on genetic variationshttps://www.fredhutch.org/en/news/releases/2015/03/aspirin-colon-cancer-prevention-link2015-03-17T17:55:37.000Z2015-03-17T17:55:37.000ZFred Hutch unleashes powerful databases with launch of ArgosFred Hutchinson Cancer Research Center, in conjunction with LabKey Software, has developed and launched Argos, an application that provides the interface and analytical power that researchers and clinicians will use to search for important patterns in cancer development, progression and treatment response.https://www.fredhutch.org/en/news/releases/2015/03/fred-hutch-launches-argos2015-03-16T22:04:41.000Z2015-03-16T22:04:41.000ZThree local organizations receive grants from Fred Hutch’s Health Disparities Research CenterA trio of local community organizations will tackle various public health challenges thanks to three small grants from Fred Hutchinson Cancer Research Center’s Health Disparities Research Center, or HDRC. The grants, co-funded by the National Institutes of Health and the HDRC, were awarded to three of six Seattle-area community-health organizations that participated in a recent grant-writing workshop sponsored by Fred Hutch.https://www.fredhutch.org/en/news/releases/2015/03/three-local-organizations-receive-fred-hutch-grants2015-03-16T19:30:58.000Z2015-03-16T19:30:58.000ZFred Hutchinson Cancer Research Center announces 2015 Harold M. Weintraub Graduate Student AwardeesThirteen graduate students from institutes throughout the United States and the United Kingdom have been chosen to receive the 2015 Harold M. Weintraub Graduate Student Award sponsored by the Basic Sciences Division of Fred Hutchinson Cancer Research Center.https://www.fredhutch.org/en/news/releases/2015/03/fred-hutch-announces-weintraub-graduate-student-awardees2015-03-10T19:48:18.000Z2015-03-10T19:48:18.000ZFred Hutch health economist Gary Lyman edits essential reference book for clinical oncologistshttps://www.fredhutch.org/en/news/releases/2015/02/gary-lyman-edits-clinical-oncology-book2015-02-27T23:01:21.000Z2015-02-27T23:01:21.000ZFred Hutch approved for a $7.75M award by the Patient-Centered Outcomes Research InstituteA research team led by Scott Ramsey, M.D., Ph.D., director of the Hutchinson Institute for Cancer Outcomes Research, or HICOR, has been approved for a $7.75 million, four-year funding award by the Patient-Centered Outcomes Research Institute, or PCORI, an independent, nonprofit organization based in Washington, D.C. The award will be used to conduct a pragmatic clinical trial evaluating the use of colony stimulating factors to reduce the risk of serious infection in patients undergoing chemotherapy for breast, colorectal or lung cancer.https://www.fredhutch.org/en/news/releases/2015/02/7M-award-to-fred-hutch-pragmatic-trial2015-02-25T01:23:57.000Z2015-02-25T01:23:57.000ZFred Hutch researcher Gerald Smith named a fellow of the American Academy of Microbiologyhttps://www.fredhutch.org/en/news/releases/2015/02/gerald-smith-named-fellow-of-aam2015-02-24T21:17:54.000Z2015-02-24T21:17:54.000ZFred Hutch researcher Robert Eisenman named a fellow of the American Association for Cancer Research Academyhttps://www.fredhutch.org/en/news/releases/2015/02/robert-eisenman-named-fellow-of-aacr-academy2015-02-18T19:23:48.000Z2015-02-18T19:23:48.000Z